SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Patently unpatentable: implications of the Myriad court decision on genetic diagnostics
7 references·1 citing·32 second hop
Patently unpatentable: implications of the Myriad court decision on genetic diagnostics (2010)Patently unpatentable: implications of th…Metastasizing patent claims on BRCA1 (2010)Metastasizing patent claims o…Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis (2010)Impact of gene patents and li…View from the Bench: Patents and Material Transfers (2005)View from the Bench: Patents …Patents on Human Genes: An Analysis of Scope and Claims (2005)Patents on Human Genes: An An…Intellectual Property Landscape of the Human Genome (2005)Intellectual Property Landsca…Working Through the Patent Problem (2003)Working Through the Patent Pr…Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Services (2003)Effects of Patents and Licens…The European BRCA patent oppositions and appeals: coloring inside the lines (2013)The European BRCA patent oppo…Reforming the Patent System (2000)Genes and patent policy: rethinking intellectual property rights (2002)Will the nanomedicine “patent land grab” thwart commercialization? (2005)Patents, Biomedical Research, and Treatments: Examining Concerns, Canvassing Solutions (2007)Low-Quality Patents in the Eye of the Beholder: Evidence from Multiple Examiners (2020)Appropriating the Returns from Industrial Research and Development (1987)The Sources and Consequences of Embeddedness for the Economic Performance of Organizations: The Network Effect (1996)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience (2008)Raging Against or With the Private Marketplace? (2008)Of Mice and Academics: Examining the Effect of Openness on Innovation (2009)Standing on the Shoulders of Giants: Cumulative Research and the Patent Law (1991)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Exploring the Foundations of Cumulative Innovation: Implications for Organization Science (2007)Has the Bayh-Dole act compromised basic research? (2011)Trends in sensitivity analysis practice in the last decade (2016)Order without Law (1991)Where excludability matters: Material versus intellectual property in academic biomedical research (2007)Sabotage in Tournaments: Evidence from a Laboratory Experiment (2011)Strategic Patenting and Software Innovation (2013)Legal uncertainty in the area of genetic diagnostic testing (2009)Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law (2011)Not quite a myriad of gene patents (2013)Are the gene-patent storm clouds dissipating? A global snapshot (2015)The licensing of DNA patents by US academic institutions: an empirical survey (2006)DNA patents and diagnostics: not a pretty picture (2010)Association Of University Technology Managers (2014)The Human Genome Project as a Singular Episode in the History of Genomics (2022)Response to ‘pervasive sequence patents cover the entire human genome’ (2014)Evidence and anecdotes: an analysis of human gene patenting controversies (2006)The effects of research tool patents and licensing on biomedical innovation (2006)Does Patent Strategy Shape the Long-Run Supply of Public Knowledge? Evidence from Human Genetics (2009)
this work references cited by second hop

References

  • 2005View from the Bench: Patents and Material Transfers230 cited
  • 2005Intellectual Property Landscape of the Human Genome222 cited
  • 2003Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Services165 cited
  • 2003Working Through the Patent Problem122 cited
  • 2005Patents on Human Genes: An Analysis of Scope and Claims44 cited
  • 2010Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis40 cited
  • 2010Metastasizing patent claims on BRCA118 cited

Cited by

  • 2013The European BRCA patent oppositions and appeals: coloring inside the lines15 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work